Dg Health Cough And Chest Congestion Solution
NDC Package 55910-774-40
Package Information
Dg Health Cough And Chest Congestion (dextromethorphan hydrobromide, guaifenesin) solution is •take only as directed•only use the dose cup provided•do not exceed 6 doses per 24 hours adults and children 12 years and over 30 mL every 4 hours children 6 to under 12 years 15 mL every 4 hours children 4 to under 6 years ask a doctor children under 4 years do not use. This formulation utilizes a solution delivery system. Marketed by Dolgencorp Inc, this product is identified by NDC 55910-774 and is authorized under FDA application M012.
Identification & Billing
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 55910 - Dolgencorp Inc
- 55910-774 - Dg Health Cough And Chest Congestion
- 55910-774-40 - 355 mL in 1 BOTTLE
- 55910-774 - Dg Health Cough And Chest Congestion
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55910-774-40 identifies a specific commercial package of 355 ml in 1 bottle of Dg Health Cough And Chest Congestion, a human over the counter drug labeled by Dolgencorp Inc. This solution is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dolgencorp Inc on July 01, 2026. The current certification is valid through December 31, 2027.
How is this Dolgencorp Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910077440. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.